Detalhe da pesquisa
1.
Time to steroids impacts visual outcome of optic neuritis in MOGAD.
J Neurol Neurosurg Psychiatry
; 94(4): 309-313, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36600666
2.
Improving the decision to switch from first- to second-line therapy in multiple sclerosis: A dynamic scoring system.
Mult Scler
; 29(2): 236-247, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36515394
3.
Cumulative effects of therapies on disability in relapsing multiple sclerosis.
Mult Scler
; 27(11): 1760-1770, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33403937
4.
BEST-MS: A prospective head-to-head comparative study of natalizumab and fingolimod in active relapsing MS.
Mult Scler
; 27(10): 1556-1563, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33124504
5.
Assessing the experience of the quality of care of patients living with multiple sclerosis and their caregivers: The MusiCare questionnaire.
Eur J Neurol
; 28(3): 910-920, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33326668
6.
Outcome and risk of recurrence in a large cohort of idiopathic longitudinally extensive transverse myelitis without AQP4/MOG antibodies.
J Neuroinflammation
; 17(1): 128, 2020 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-32326965
7.
High-dose biotin in progressive multiple sclerosis: A prospective study of 178 patients in routine clinical practice.
Mult Scler
; 26(14): 1898-1906, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31845825
8.
An intermediate level of CD161 expression defines a novel activated, inflammatory, and pathogenic subset of CD8+ T cells involved in multiple sclerosis.
J Autoimmun
; 88: 61-74, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29054368
9.
Neuropathologic, phenotypic and functional analyses of Mucosal Associated Invariant T cells in Multiple Sclerosis.
Clin Immunol
; 166-167: 1-11, 2016 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27050759
10.
Oral versus intravenous high-dose methylprednisolone for treatment of relapses in patients with multiple sclerosis (COPOUSEP): a randomised, controlled, double-blind, non-inferiority trial.
Lancet
; 386(9997): 974-81, 2015 Sep 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-26135706
11.
Adult-onset genetic leukoencephalopathies: a MRI pattern-based approach in a comprehensive study of 154 patients.
Brain
; 138(Pt 2): 284-92, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25527826
12.
Unaltered regulatory B-cell frequency and function in patients with multiple sclerosis.
Clin Immunol
; 155(2): 198-208, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-25267439
13.
Efficacy and comparison of corticosteroids only and corticosteroids with plasmapheresis or intravenous immunoglobulin for the treatment of optic neuritis in demyelinating disease: A systematic review and network meta-analysis.
Mult Scler Relat Disord
; 85: 105521, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38457882
14.
Investigating the metabolite signature of an altered oral microbiota as a discriminant factor for multiple sclerosis: a pilot study.
Sci Rep
; 14(1): 7786, 2024 04 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38565581
15.
Highly Effective Therapies as First-Line Treatment for Pediatric-Onset Multiple Sclerosis.
JAMA Neurol
; 81(3): 273-282, 2024 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38345791
16.
Peer support impact on therapeutic adherence in patients with multiple sclerosis: a mixed-methods pilot trial protocol.
BMJ Open
; 13(12): e071336, 2023 12 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-38159942
17.
Discontinuation of second- versus first-line disease-modifying treatment in middle-aged patients with multiple sclerosis.
J Neurol
; 270(1): 413-422, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36121558
18.
Aglycosylated extracellular loop of inwardly rectifying potassium channel 4.1 (KCNJ10) provides a target for autoimmune neuroinflammation.
Brain Commun
; 5(2): fcad044, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36910419
19.
Immune Profiling Reveals the T-Cell Effect of Ocrelizumab in Early Relapsing-Remitting Multiple Sclerosis.
Neurol Neuroimmunol Neuroinflamm
; 10(3)2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36810163
20.
Teriflunomide and Time to Clinical Multiple Sclerosis in Patients With Radiologically Isolated Syndrome: The TERIS Randomized Clinical Trial.
JAMA Neurol
; 80(10): 1080-1088, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37603328